Home/NuCana/Theresa Bruce
TB

Theresa Bruce

Chief Operating Officer

NuCana

Therapeutic Areas

NuCana Pipeline

DrugIndicationPhase
NUC-3373Colorectal Cancer & other solid tumorsPhase 1/2
NUC-7738Advanced solid tumors, PD-1-Resistant MelanomaPhase 1/2
Acelarin (NUC-1031)Biliary Tract Cancer, Ovarian CancerPhase 3